Obinutuzumab Is a Promising Alternative for the Treatment of Relapsed or Refractory Autoimmune Hematological Disorders
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Haiju He, Hong Tian, Yun Li, Ziqiang Yu, Depei Wu, Jie Yin
Institution: First Affiliated Hospital of Soochow University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405034730